{"id":"https://openalex.org/W22401950","doi":null,"title":"Patr\u00f3n de sensibilidad de aislamientos cl\u00ednicos de Acinetobacter baumannii en Madrid vs. Hong Kong","display_name":"Patr\u00f3n de sensibilidad de aislamientos cl\u00ednicos de Acinetobacter baumannii en Madrid vs. Hong Kong","alternate_titles":[],"publication_year":2006,"publication_date":"2006-01-01","ids":{"openalex":"https://openalex.org/W22401950","mag":"22401950"},"language":"es","primary_location":{"id":"mag:22401950","doi":null,"is_oa":false,"landing_page_url":"http://seq.es/seq/0214-3429/19/1/Garcia-Penuela.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S976986303","display_name":"Revista espa\u00f1ola de quimioterapia. Suplemento","issn_l":"1130-331X","issn":["1130-331X"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Revista espa\u00f1ola de quimioterapia. Suplemento","raw_type":null},"parent_works":[],"lineage":["https://openalex.org/W22401950"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5106512727","display_name":"Teresa Alarc\u00f3n","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Teresa Alarc\u00f3n","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053186803","display_name":"Manuel L\u00f3pez Brea","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Manuel L\u00f3pez Brea","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029068608","display_name":"E. Garc\u00eda Pe\u00f1uela","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"E. Garc\u00eda Pe\u00f1uela","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"Esteban Aznar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Esteban Aznar","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.1873,"has_fulltext":false,"cited_by_count":9,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.53327418,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":96},"biblio":{"volume":"19","issue":"1","first_page":"45","last_page":"50"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12824","display_name":"Infections and bacterial resistance","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acinetobacter-baumannii","display_name":"Acinetobacter baumannii","score":1.0},{"id":"https://openalex.org/keywords/antimicrobial-susceptibility","display_name":"antimicrobial susceptibility","score":0.8560000061988831},{"id":"https://openalex.org/keywords/antimicrobial-resistance","display_name":"antimicrobial resistance","score":0.7239999771118164},{"id":"https://openalex.org/keywords/clinical-isolates","display_name":"clinical isolates","score":0.7059999704360962},{"id":"https://openalex.org/keywords/madrid","display_name":"Madrid","score":0.4830000102519989},{"id":"https://openalex.org/keywords/hong-kong","display_name":"Hong Kong","score":0.9990000128746033},{"id":"https://openalex.org/keywords/cefotaxime-resistance","display_name":"cefotaxime resistance","score":0.597000002861023},{"id":"https://openalex.org/keywords/ofloxacin-resistance","display_name":"ofloxacin resistance","score":0.8069999814033508},{"id":"https://openalex.org/keywords/colistin","display_name":"colistin","score":0.8379999995231628},{"id":"https://openalex.org/keywords/imipenem","display_name":"imipenem","score":0.8730000257492065},{"id":"https://openalex.org/keywords/tobramycin","display_name":"tobramycin","score":0.8830000162124634},{"id":"https://openalex.org/keywords/amikacin","display_name":"amikacin","score":0.9229999780654907},{"id":"https://openalex.org/keywords/sulbactam","display_name":"sulbactam","score":0.8880000114440918},{"id":"https://openalex.org/keywords/carbapenem-resistance","display_name":"carbapenem resistance","score":0.6930000185966492},{"id":"https://openalex.org/keywords/cross-resistance","display_name":"cross-resistance","score":0.7229999899864197},{"id":"https://openalex.org/keywords/nosocomial-infections","display_name":"nosocomial infections","score":0.42399999499320984}],"concepts":[{"id":"https://openalex.org/C2776315533","wikidata":"https://www.wikidata.org/wiki/Q3241189","display_name":"Acinetobacter baumannii","level":4,"score":0.7262036204338074},{"id":"https://openalex.org/C2778478555","wikidata":"https://www.wikidata.org/wiki/Q423393","display_name":"Sulbactam","level":5,"score":0.7030857801437378},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4910869598388672},{"id":"https://openalex.org/C2778523567","wikidata":"https://www.wikidata.org/wiki/Q310457","display_name":"Acinetobacter","level":3,"score":0.47662627696990967},{"id":"https://openalex.org/C2779631663","wikidata":"https://www.wikidata.org/wiki/Q425152","display_name":"Imipenem","level":4,"score":0.4316375255584717},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.38584214448928833},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.2263491153717041},{"id":"https://openalex.org/C94665300","wikidata":"https://www.wikidata.org/wiki/Q63391344","display_name":"Antibiotic resistance","level":3,"score":0.10788381099700928},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.09952086210250854},{"id":"https://openalex.org/C523546767","wikidata":"https://www.wikidata.org/wiki/Q10876","display_name":"Bacteria","level":2,"score":0.04578390717506409},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C2777637488","wikidata":"https://www.wikidata.org/wiki/Q31856","display_name":"Pseudomonas aeruginosa","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:22401950","doi":null,"is_oa":false,"landing_page_url":"http://seq.es/seq/0214-3429/19/1/Garcia-Penuela.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S976986303","display_name":"Revista espa\u00f1ola de quimioterapia. Suplemento","issn_l":"1130-331X","issn":["1130-331X"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Revista espa\u00f1ola de quimioterapia. Suplemento","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":23,"referenced_works":["https://openalex.org/W1785819724","https://openalex.org/W1790773676","https://openalex.org/W1943640785","https://openalex.org/W1977021452","https://openalex.org/W1994290814","https://openalex.org/W1998549508","https://openalex.org/W2000554844","https://openalex.org/W2004533104","https://openalex.org/W2045554207","https://openalex.org/W2048310785","https://openalex.org/W2050315625","https://openalex.org/W2064791632","https://openalex.org/W2074042278","https://openalex.org/W2097045334","https://openalex.org/W2110256580","https://openalex.org/W2124996394","https://openalex.org/W2126332285","https://openalex.org/W2130764129","https://openalex.org/W2132578487","https://openalex.org/W2145645537","https://openalex.org/W2156864760","https://openalex.org/W2167386948","https://openalex.org/W2168042802"],"related_works":["https://openalex.org/W2417801734","https://openalex.org/W1995689230","https://openalex.org/W2349498311","https://openalex.org/W2055846623","https://openalex.org/W2034012142","https://openalex.org/W2390526261","https://openalex.org/W1559402184","https://openalex.org/W7132749050","https://openalex.org/W7119430294","https://openalex.org/W2376461591"],"abstract_inverted_index":{"El":[0,111],"objetivo":[1],"de":[2,9,14,16,24,27,31,33,42,47,51,60,67,76,78,105,115,126,130,136,154,160,169,174,178,210,219,225,255,257],"este":[3],"estudio":[4],"fue":[5],"comparar":[6],"el":[7,21,30,38,90,94,103,231,234,236],"patron":[8],"sensibilidad":[10,170,202,256],"a":[11,96,141,151,171,197,217,240],"siete":[12,68],"antimicrobianos":[13,69,227],"cepas":[15,32,56,119,138,155,161,164,214],"Acinetobacter":[17,82],"baumannii":[18,35,259],"aisladas":[19,36],"en":[20,37,72,87,117,212,245,251],"Hospital":[22,39],"Universitario":[23],"la":[25,65,99,109,172,198,223,241],"Princesa,":[26],"Madrid,":[28],"con":[29],"A.":[34,258],"Queen":[40],"Mary,":[41],"Hong":[43,61,220,246,270],"Kong,":[44],"desde":[45],"enero":[46],"2004":[48,88],"hasta":[49],"marzo":[50],"2005.":[52],"Se":[53,63],"estudiaron":[54],"74":[55],"espanolas":[57,120,215],"y":[58,129,144,157,185,192,195,248,269],"30":[59],"Kong.":[62,271],"determino":[64],"CMI":[66,80],"mediante":[70],"dilucion":[71],"agar.":[73],"Los":[74,253],"puntos":[75],"corte":[77,106],"las":[79,118,137,213,218],"para":[81,98,181,189,222,233],"spp.":[83],"fueron":[84,139,149],"los":[85,175,226],"aprobados":[86],"por":[89,108],"NCCLS":[91],"(para":[92],"sulbactam,":[93,183],"correspondiente":[95],"ampicilina-sulbactam);":[97],"colistina":[100,123],"se":[101,206],"considero":[102],"punto":[104],"recomendado":[107],"BSAC.":[110],"porcentaje":[112,237],"mas":[113],"alto":[114],"actividad":[116],"lo":[121],"presento":[122],"(98,64%),":[124],"seguida":[125],"imipenem":[127,190],"(94,59%)":[128],"tobramicina":[131,184],"(78,37%).":[132],"Alrededor":[133],"del":[134],"50%":[135],"sensibles":[140,244],"sulbactam":[142],"(54,05%)":[143],"amikacina":[145],"(51,35%).":[146],"La":[147],"mayoria":[148,173,224],"resistentes":[150,250],"ofloxacino":[152,193],"(2,7%":[153],"sensibles)":[156],"ceftazidima":[158,199],"(1,35%":[159],"sensibles).":[162],"Las":[163],"chinas":[165],"presentaron":[166,200],"elevados":[167],"porcentajes":[168,209],"antimicrobianos,":[176],"siendo":[177],"un":[179],"96,66%":[180],"colistina,":[182],"amikacina,":[186],"algo":[187],"inferior":[188],"(93,33%)":[191],"(90%),":[194],"solo":[196],"baja":[201],"(10%).":[203],"En":[204],"conclusion,":[205],"encontraron":[207],"mayores":[208],"resistencia":[211],"frente":[216],"Kong":[221,247],"probados.":[228],"Cabe":[229],"destacar":[230],"ofloxacino,":[232],"cual":[235],"es":[238],"practicamente":[239],"inversa":[242],"(90%":[243],"93%":[249],"Madrid).":[252],"patrones":[254],"presentan":[260],"importantes":[261],"diferencias":[262],"entre":[263],"lugares":[264],"tan":[265],"distantes":[266],"como":[267],"Madrid":[268]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W22401950","counts_by_year":[{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
